Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses
Jianli He, … , Tianshi Wang, Jinke Cheng
Jianli He, … , Tianshi Wang, Jinke Cheng
Published August 15, 2024
Citation Information: J Clin Invest. 2024;134(16):e176586. https://doi.org/10.1172/JCI176586.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 1

Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses

  • Text
  • PDF
Abstract

T cells rewire their metabolic activities to meet the demand of immune responses, but how to coordinate the immune response by metabolic regulators in activated T cells is unknown. Here, we identified autocrine VEGF-B as a metabolic regulator to control lipid synthesis and maintain the integrity of the mitochondrial inner membrane for the survival of activated T cells. Disruption of autocrine VEGF-B signaling in T cells reduced cardiolipin mass, resulting in mitochondrial damage, with increased apoptosis and reduced memory development. The addition of cardiolipin or modulating VEGF-B signaling improved T cell mitochondrial fitness and survival. Autocrine VEGF-B signaling through GA-binding protein α (GABPα) induced sentrin/SUMO-specific protease 2 (SENP2) expression, which further de-SUMOylated PPARγ and enhanced phospholipid synthesis, leading to a cardiolipin increase in activated T cells. These data suggest that autocrine VEGF-B mediates a signal to coordinate lipid synthesis and mitochondrial fitness with T cell activation for survival and immune response. Moreover, autocrine VEGF-B signaling in T cells provides a therapeutic target against infection and tumors as well as an avenue for the treatment of autoimmune diseases.

Authors

Jianli He, Yalan Chen, Huihua Ding, Jin-An Zhou, Zhengcao Xing, Xinyu Yang, Qiuju Fan, Yong Zuo, Tianshi Wang, Jinke Cheng

×

Figure 1

TCR activation induces VEGF-B protein expression in T cells.

Options: View larger image (or click on image) Download as PowerPoint
TCR activation induces VEGF-B protein expression in T cells.
(A) Relativ...
(A) Relative mRNA levels of the secreted factors in CD8+ Tn cells treated with or without (NA) αCD3/CD28 for 3 days; n = 3. Prf1, Ifng, Gzmb, and Tnf were positive indicators for T cell activation. (B) VEGF-B protein levels in NA or activated CD4+ and CD8+ T cells; n = 3. (C) Immunofluorescence images of VEGF-B in NA or activated CD4+ or CD8+ T cells. DAPI staining is in blue. Scale bar: 2 μm. (D) The mean fluorescent intensity (MFI) of VEGF-B in NA or activated CD4+ or CD8+ T cells; n = 3. (E) The population of VEGF-B+ and IFN-γ+ in NA or activated CD8+ T cells; n = 3. (F) VEGF-B protein levels in culture supernatants of NA or activated CD4+ or CD8+ T cells; n = 3. (G) The population of VEGF-B+ and H-2Kb+ cells in CD8+ T cells from the spleen of OT-1 mice infected by LM-OVA for 3 days; n = 5. (H) The population of VEGF-B+ cells in CD4+ or CD8+ T cells from colon tissue with DSS-induced colitis; n = 6. Data are shown as mean ± SEM. P values were calculated using 2-tailed unpaired t test in F. *P < 0.05, **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
7 readers on Mendeley
See more details